Technical

Technology Platform

Products

Intellectual property

China’s first clinical trial treating ischemic stroke with an imported stem cell product was formally launched.

China’s first clinical trial treating ischemic stroke with an imported stem cell product was formally launched. 

Previous

Jiuzhitang Maker received fund support from Daxing District Program for Advancing Transfer and Transformation of Technological Achievements.

Jiuzhitang Maker was awarded the prize of "Excellent Enterprise Assuming Social Responsibilities in 2020" by Health News.

Next